EP1434645A4 - Entfernung von metabolischen komponenten aus blut - Google Patents

Entfernung von metabolischen komponenten aus blut

Info

Publication number
EP1434645A4
EP1434645A4 EP02759922A EP02759922A EP1434645A4 EP 1434645 A4 EP1434645 A4 EP 1434645A4 EP 02759922 A EP02759922 A EP 02759922A EP 02759922 A EP02759922 A EP 02759922A EP 1434645 A4 EP1434645 A4 EP 1434645A4
Authority
EP
European Patent Office
Prior art keywords
extraction
blood constituents
metabolic blood
metabolic
constituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02759922A
Other languages
English (en)
French (fr)
Other versions
EP1434645A1 (de
Inventor
Steven Anthony Botto
Philip John Roeth
Ellie Louise Faramus
Chenicheri Hariharan Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Therapeutics Ltd
Original Assignee
Gradipore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gradipore Ltd filed Critical Gradipore Ltd
Publication of EP1434645A1 publication Critical patent/EP1434645A1/de
Publication of EP1434645A4 publication Critical patent/EP1434645A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1603—Regulation parameters
    • A61M1/1605—Physical characteristics of the dialysate fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D57/00—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C
    • B01D57/02—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C by electrophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3324—PH measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3344—Measuring or controlling pressure at the body treatment site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3368—Temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Electrochemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Electrostatic Separation (AREA)
EP02759922A 2001-09-04 2002-09-04 Entfernung von metabolischen komponenten aus blut Withdrawn EP1434645A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR7485A AUPR748501A0 (en) 2001-09-04 2001-09-04 Renal dialysis
AUPR748501 2001-09-04
PCT/AU2002/001217 WO2003020403A1 (en) 2001-09-04 2002-09-04 Removal of metabolic components from blood

Publications (2)

Publication Number Publication Date
EP1434645A1 EP1434645A1 (de) 2004-07-07
EP1434645A4 true EP1434645A4 (de) 2006-12-13

Family

ID=3831435

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02759922A Withdrawn EP1434645A4 (de) 2001-09-04 2002-09-04 Entfernung von metabolischen komponenten aus blut

Country Status (5)

Country Link
EP (1) EP1434645A4 (de)
JP (1) JP4181038B2 (de)
CN (1) CN1551795A (de)
AU (1) AUPR748501A0 (de)
WO (1) WO2003020403A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5121449B2 (ja) * 2005-05-26 2013-01-16 株式会社サインポスト 疾患の発症予測提示方法
JP4947693B2 (ja) * 2006-07-14 2012-06-06 学校法人北里研究所 アルブミンとアルブミンに結合した生体分子の分離方法
EP2087916A1 (de) 2008-02-11 2009-08-12 ICinnovation BV Elektrosorptionsvorrichtung zur Reinigung von Blut und anderen Flüssigkeiten
US10626399B2 (en) 2010-01-28 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
US20160208011A1 (en) 2010-01-28 2016-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
KR101848527B1 (ko) * 2010-06-28 2018-04-12 옵토플루이드 테크놀로지스 오유 생물학적 유체 내 중간 및 단백질 결합 요독의 함량 측정 방법 및 장치
EP2446908B1 (de) 2010-11-02 2015-07-15 ICinnovation BV Elektrosorptions- und Zersetzungsvorrichtung zur Reinigung von Blut und anderen Flüssigkeiten
US9161968B2 (en) 2011-04-08 2015-10-20 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
DE102011078695A1 (de) 2011-07-05 2013-01-10 Charité - Universitätsmedizin Berlin Dialyseverfahren zur Entfernung proteingebundener Toxine aus dem Blut von Patienten unter Einsatz hochfrequenter elektromagnetischer Felder
DE102012025052A1 (de) * 2012-12-20 2014-06-26 Fresenius Medical Care Deutschland Gmbh Hämodiafiltrationsverfahren
ES2478695B1 (es) * 2012-12-20 2015-04-28 Servicio Andaluz De Salud Dispositivo para inducir hipotermia terapéutica
DE102012025164A1 (de) * 2012-12-21 2014-06-26 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Entfernung proteingebundener Toxine aus Blutplasma
DE102013100050A1 (de) * 2013-01-04 2014-07-10 Charité - Universitätsmedizin Berlin Vorrichtung und Verfahren zur Entfernung proteingebundener Toxine aus dem Blut von Patienten unter Einsatz eines hochfrequenten, elektromagnetischen Feldes und eines elektrostatischen Gleichfeldes
EP2862584B1 (de) 2013-10-21 2019-03-20 ICinnovation BV Elektrosorptions- und Zersetzungsvorrichtung zur Reinigung von Blut und anderen Flüssigkeiten
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
JP6667438B2 (ja) 2013-12-09 2020-03-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 老化に関連する状態を処置する方法及び組成物
KR101552519B1 (ko) 2014-05-13 2015-09-14 계명대학교 산학협력단 심혈관 질환 예방을 위한 지방 분리 시스템 및 지방 분리 방법
CN104404008A (zh) * 2014-12-10 2015-03-11 辽宁省海洋水产科学研究院 一种海胆多功能肌动蛋白的分离纯化方法
CN107921188A (zh) 2015-05-18 2018-04-17 小利兰·斯坦福大学托管委员会 用于治疗衰老相关的损伤的方法和组合物
ES2902467T3 (es) 2015-06-15 2022-03-28 Univ Leland Stanford Junior TIMP2 para su uso en el tratamiento de afecciones asociadas al envejecimiento
MX2020009679A (es) * 2018-08-17 2020-10-12 Univ Washington Aparato y metodo para foto-oxidacion de urea.
CN109358105B (zh) * 2018-09-26 2021-01-05 陕西绿盾环境工程研究院有限公司 一种减少春雷霉素残渣中春雷霉素含量装置及方法
CN110817802B (zh) * 2019-10-24 2023-01-24 邯郸钢铁集团有限责任公司 一种利用复合纯化工艺制取超纯氢的系统及方法
CN111407943A (zh) * 2020-04-25 2020-07-14 宁波高新区零零七工业设计有限公司 一种病毒吸附分离无害化处理设备及其处理方法
CN113181458A (zh) * 2021-04-22 2021-07-30 浙大宁波理工学院 人工肝的生物反应器

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870617A (en) * 1971-03-30 1975-03-11 Rhone Poulenc Sa Apparatus for forced flow electrophoresis
US3989613A (en) * 1973-05-16 1976-11-02 The Dow Chemical Company Continuous balanced flow fixed boundary electrophoresis
US4655898A (en) * 1984-08-06 1987-04-07 Rhone-Poulenc Recherches Electrophoretic fractionation apparatus
WO2000013776A1 (en) * 1998-09-07 2000-03-16 Gradipore Limited Cassette for macromolecule purification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276140A (en) * 1980-01-10 1981-06-30 Ionics Inc. Electrodialysis apparatus and process for fractionating protein mixtures
JPS62172965A (ja) * 1986-01-27 1987-07-29 日東電工株式会社 血液処理装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870617A (en) * 1971-03-30 1975-03-11 Rhone Poulenc Sa Apparatus for forced flow electrophoresis
US3989613A (en) * 1973-05-16 1976-11-02 The Dow Chemical Company Continuous balanced flow fixed boundary electrophoresis
US4655898A (en) * 1984-08-06 1987-04-07 Rhone-Poulenc Recherches Electrophoretic fractionation apparatus
WO2000013776A1 (en) * 1998-09-07 2000-03-16 Gradipore Limited Cassette for macromolecule purification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03020403A1 *

Also Published As

Publication number Publication date
JP2005527247A (ja) 2005-09-15
WO2003020403A1 (en) 2003-03-13
JP4181038B2 (ja) 2008-11-12
AUPR748501A0 (en) 2001-09-27
CN1551795A (zh) 2004-12-01
EP1434645A1 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
EP1471839A4 (de) Einführanordnung für medizinische instrumente
HUS1500048I1 (hu) Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére
DE50208638D1 (de) Katheter
DE60225431D1 (de) Dialysekatheter
DE60308293D1 (de) Blutbehandlungskathetereinrichtung
DE60237823D1 (de) Medizinisches behandlungsinstrument
DE60334146D1 (de) Poly-hema-zusammensetzungen mit niedriger polydispersität
DE60325879D1 (de) Selbstverschliessende kanüle
DE60311176D1 (de) Verfahren zur Herstellung von Vorrichtungen zur Entnahme von physiologischen Proben
NO20030400D0 (no) Fottöy med festbar gamasje
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
EP1494699A4 (de) Verfahren zur hemmung der vaskulären hyperpermeabilität
EP1485109A4 (de) Gefässtherapeutika
DE50207147D1 (de) Endoskopischer Katheter
DE60304223D1 (de) Herstellung von metallamid-komplexen
DE602004030605D1 (de) Herstellung von titanoxid
SE0402458L (sv) Igensättningsmotverkande behandlingar
DE60220220D1 (de) Blutbehandlungssystem
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DE602004029125D1 (de) Umhüllung von elektrischem Gerät
DE60217780D1 (de) Skischuh
DE602004013599D1 (de) Herstellung von somatostatinpeptiden
DE50209299D1 (de) Chirurgisches schälmesser
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040402

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20061115

RIC1 Information provided on ipc code assigned before grant

Ipc: B01D 57/02 20060101ALI20061109BHEP

Ipc: A61M 1/16 20060101AFI20061109BHEP

17Q First examination report despatched

Effective date: 20070820

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIFE THERAPEUTICS LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110401